Spectrum-2
Oximeter, Tissue Saturation. 510(k) K254129, from Neko Health AB (Danderyd, SE). Product code MUD, class 2.
As of Nov 18, 2026, K254129 is an FDA 510(k) held by Neko Health AB, substantially equivalent on May 22, 2026 after 151 days, with no recalls tied to it in FDA's recall database.
- Review time: 151 days
- Recalls: 0
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFThe Spectrum-2 device is indicated for use to record and monitor changes in oxygenation levels in superficial tissues during circulatory or perfusion examinations for individuals with potential circulatory compromise.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Clarifi Imaging SystemK181623 · Modulated Imaging, Inc. · Jul 19, 2018
Other MUD clearances
The newest 510(k)s for the same product code; their median review was 125 days; see every MUD device- OxySight for MolecuLightDX+K262858 · MolecuLight, Inc. · Nov 5, 2026
- Masimo O3 Regional OximeterK243324 · Masimo Corporation · Jul 17, 2025
- Lap.Ox™ Laparoscopic Tissue OximeterK250519 · ViOptix, Inc. · Jun 26, 2025
- Cerebral Autoregulation Index (CAI) AlgorithmK240596 · Edwards Lifesciences · Oct 16, 2024
- ODI-TechK241393 · Odi Medical AS · Aug 30, 2024
- SnapshotNIR model KD205K240601 · Kent Imaging, Inc. · Apr 2, 2024
- OxiplexTS200K232385 · Iss Medical, Inc. · Mar 1, 2024
- Intra.Ox™ 2.0 Handheld Tissue OximeterK233488 · Vioptix, Inc. · Feb 28, 2024
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 22, 2025
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.2700
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files